Curing TB with open science

Tuberculosis

Volumn 94, Issue 2, 2014, Pages 183-185

  Ekins, Sean ^a,b   Williams, Antony J ^c  

^a Collaborations in Chemistry ^*  (United States)

^b Collaborative Drug Discovery ^*  (United States)

^c ROYAL SOCIETY OF CHEMISTRY   (United Kingdom)

Author keywords

Collaboration; Coordination; Data silos; Open science

Indexed keywords

BEDAQUILINE; BCG VACCINE; TUBERCULOSTATIC AGENT;

ARTICLE; DRUG DEVELOPMENT; DRUG INDUSTRY; DRUG RESEARCH; DRUG STRUCTURE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INDIA; MOBILE APPLICATION; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; TUBERCULOSIS; ATTITUDE TO HEALTH; COOPERATION; FEMALE; HEALTH; MALE; ORGANIZATION AND MANAGEMENT; RESEARCH;

ANTITUBERCULAR AGENTS; ATTITUDE TO HEALTH; COOPERATIVE BEHAVIOR; DRUG DISCOVERY; FEMALE; GLOBAL HEALTH; HUMANS; MALE; RESEARCH; TUBERCULOSIS; TUBERCULOSIS VACCINES;

EID: 84893958919     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2013.10.002     Document Type: Article

References (31)

1. E.L. Ponder, J.S. Freundlich, M. Sarker, and S. Ekins Computational models for neglected diseases: gaps and opportunities Pharm Res 2013 [in Press]
2. E.B. Wong, K.A. Cohen, and W.R. Bishai Rising to the challenge: new therapies for tuberculosis Trends Microbiol 21 2013 493 501
3. Z. Ma, C. Lienhardt, H. McIlleron, A.J. Nunn, and X. Wang Global tuberculosis drug development pipeline: the need and the reality Lancet 375 2010 2100 2109
4. J.H. Grosset, T.G. Singer, and W.R. Bishai New drugs for the treatment of tuberculosis: hope and reality Int J Tuberc Lung Dis 16 2012 1005 1014
5. S. Ekins, J.S. Freundlich, J.V. Hobrath, E.L. White, and R.C. Reynolds Combining computational methods for hit to lead optimization in Mycobacterium tuberculosis drug discovery Pharm Res 2013 [in Press]
6. R.C. Reynolds, S. Ananthan, E. Faaleolea, J.V. Hobrath, C.D. Kwong, C. Maddox, L. Rasmussen, M.I. Sosa, E. Thammasuvimol, E.L. White, W. Zhang, and J.A. Secrist III High throughput screening of a library based on kinase inhibitor scaffolds against Mycobacterium tuberculosis H37Rv Tuberculosis (Edinburgh, Scotland) 92 2012 72 83
7. J.A. Maddry, S. Ananthan, R.C. Goldman, J.V. Hobrath, C.D. Kwong, C. Maddox, L. Rasmussen, R.C. Reynolds, J.A. Secrist 3rd, M.I. Sosa, E.L. White, and W. Zhang Antituberculosis activity of the molecular libraries screening center network library Tuberculosis (Edinburgh, Scotland) 89 2009 354 363
8. S. Ananthan, E.R. Faaleolea, R.C. Goldman, J.V. Hobrath, C.D. Kwong, B.E. Laughon, J.A. Maddry, A. Mehta, L. Rasmussen, R.C. Reynolds, J.A. Secrist 3rd, N. Shindo, D.N. Showe, M.I. Sosa, W.J. Suling, and E.L. White High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv Tuberculosis (Edinburgh, Scotland) 89 2009 334 353
9. L. Ballell, R.H. Bates, R.J. Young, D. Alvarez-Gomez, E. Alvarez-Ruiz, V. Barroso, D. Blanco, B. Crespo, J. Escribano, R. Gonzalez, S. Lozano, S. Huss, A. Santos-Villarejo, J.J. Martin-Plaza, A. Mendoza, M.J. Rebollo-Lopez, M. Remuinan-Blanco, J.L. Lavandera, E. Perez-Herran, F.J. Gamo-Benito, J.F. Garcia-Bustos, D. Barros, J.P. Castro, and N. Cammack Fueling open-source drug discovery: 177 small-molecule leads against tuberculosis ChemMedChem 8 2013 313 321
10. P.A. Mak, S.P. Rao, M. Ping Tan, X. Lin, J. Chyba, J. Tay, S.H. Ng, B.H. Tan, J. Cherian, J. Duraiswamy, P. Bifani, V. Lim, B.H. Lee, N. Ling Ma, D. Beer, P. Thayalan, K. Kuhen, A. Chatterjee, F. Supek, R. Glynne, J. Zheng, H.I. Boshoff, C.E. Barry 3rd, T. Dick, K. Pethe, and L.R. Camacho A High-throughput screen to identify inhibitors of ATP homeostasis in non-replicating Mycobacterium tuberculosis ACS Chem Biol 7 2012 1190 1197
11. F.-J. Gamo, L.M. Sanz, J. Vidal, C. de Cozar, E. Alvarez, J.-L. Lavandera, D.E. Vanderwall, D.V.S. Green, V. Kumar, S. Hasan, J.R. Brown, C.E. Peishoff, L.R. Cardon, and J.F. Garcia-Bustos Thousands of chemical starting points for antimalarial lead identification Nature 465 2010 305 310
12. M.N. Robertson, P.M. Ylioja, A.E. Williamson, M. Woelfle, M. Robins, K.A. Badiola, P. Willis, P. Olliaro, T.N. Wells, and M.H. Todd Open source drug discovery - a limited tutorial Parasitology 2013 1 10
13. D. Singla, M. Anurag, D. Dash, and G.P. Raghava A web server for predicting inhibitors against bacterial target GlmU protein BMC Pharmacol 11 2011 5
14. A. Bhardwaj, D. Bhartiya, N. Kumar, and V. Scaria TBrowse: an integrative genomics map of Mycobacterium tuberculosis Tuberculosis (Edinburgh, Scotland) 89 2009 386 387
15. A. Seal, P. Yogeeswari, D. Sriram, O. Consortium, and D.J. Wild Enhanced ranking of PknB inhibitors using data fusion methods J Cheminform 5 2013 2
16. C. Ardal, and J.A. Rottingen Open source drug discovery in practice: a case study PLoS Negl Trop Dis 6 2012 e1827
17. A. Slomski South Africa warns of emergence of "totally" drug-resistant tuberculosis JAMA 309 2013 1097 1098
18. S. Ekins, and B.A. Bunin The collaborative drug discovery (CDD) database Methods Mol Biol (Clifton, NJ) 993 2013 139 154
19. S. Ekins, and J.S. Freundlich Computational models for tuberculosis drug discovery Methods Mol Biol (Clifton, NJ) 993 2013 245 262
20. S. Ekins, J.S. Freundlich, I. Choi, M. Sarker, and C. Talcott Computational databases, pathway and cheminformatics tools for tuberculosis drug discovery Trends Microbiology 19 2011 65 74
21. A.J. Williams, S. Ekins, A.M. Clark, J.J. Jack, and R.L. Apodaca Mobile apps for chemistry in the world of drug discovery Drug Discov Today 16 2011 928 939
22. S. Ekins, A.M. Clark, and A.J. Williams Open drug discovery teams: a chemistry mobile app for collaboration Mol Inform 31 2012 585 597
23. S. Ekins, A.M. Clark, and M. Sarker TB mobile: a mobile app for anti-tuberculosis molecules with known targets J Cheminform 5 2013 13
24. J. Wood, L. Sames, A. Moore, and S. Ekins Multifaceted roles of ultra-rare and rare disease patients/parents in drug discovery Drug Discov Today 18 21-22 November 2013 1043 1051
25. C.L. Beaulieu, S. Ekins, M. Samuels, K.M. Boycott, and A. MacKenzie Towards the development of a generalizable pre-clinical research pathway for orphan disease therapy Orphanet J Rare Dis 7 2012 39
26. A.J. Williams, V. Tkachenko, C. Lipinski, A. Tropsha, and S. Ekins Free online resources enabling crowdsourced drug discovery Drug Discov World 10 2009 33 38 [Winter]
27. S. Ekins, and A.J. Williams Precompetitive preclinical ADME/Tox data: set it free on the web to facilitate computational model building to assist drug development Lab a Chip 10 2010 13 22
28. S. Ekins, and A.J. Williams Reaching out to collaborators: crowdsourcing for pharmaceutical research Pharm Res 27 2010 393 395
29. A.J. Williams, J. Wilbanks, and S. Ekins Why open drug discovery needs four simple rules for licensing data and models PLoS Comput Biol 8 2012 e1002706
30. S. Ekins, C.L. Waller, M.P. Bradley, A.M. Clark, and A.J. Williams Four disruptive strategies for removing drug discovery bottlenecks Drug Disc Today 18 2013 265 271
31. A. Bingham, and S. Ekins Competitive collaboration in the pharmaceutical and biotechnology industry Drug Disc Today 14 2009 1079 1081